IL13 and Alzheimer disease: Actually, galectin-7 expression levels in the stratum corneum and serum galectin-7 levels were correlated with TEWL in AD patients [15,30], suggesting that galectin-7 expression is a potential biomarker of IL-4/IL-13–induced skin barrier dysfunction.